国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pseudomonas aeruginosa Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP487380EZY
CSB-EP487380EZY
CSB-BP487380EZY
CSB-MP487380EZY
CSB-EP487380EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L19 (rplS) CSB-YP487381EZY
CSB-EP487381EZY
CSB-BP487381EZY
CSB-MP487381EZY
CSB-EP487381EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Soluble pyridine nucleotide transhydrogenase (sthA) CSB-YP487382EZY
CSB-EP487382EZY
CSB-BP487382EZY
CSB-MP487382EZY
CSB-EP487382EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C CSB-YP487383EZY
CSB-EP487383EZY
CSB-BP487383EZY
CSB-MP487383EZY
CSB-EP487383EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa DNA gyrase inhibitor YacG (yacG) CSB-YP487384EZY
CSB-EP487384EZY
CSB-BP487384EZY
CSB-MP487384EZY
CSB-EP487384EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Ribosomal RNA small subunit methyltransferase C (rsmC) CSB-YP487385EZY
CSB-EP487385EZY
CSB-BP487385EZY
CSB-MP487385EZY
CSB-EP487385EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Outer-membrane lipoprotein lolB (lolB) CSB-YP487386EZY
CSB-EP487386EZY
CSB-BP487386EZY
CSB-MP487386EZY
CSB-EP487386EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Chromosomal replication initiator protein DnaA (dnaA), partial CSB-YP487387EZY
CSB-EP487387EZY
CSB-BP487387EZY
CSB-MP487387EZY
CSB-EP487387EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Photosystem II reaction center protein Z (psbZ), partial CSB-YP487388DZZ1
CSB-EP487388DZZ1
CSB-BP487388DZZ1
CSB-MP487388DZZ1
CSB-EP487388DZZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP487389DZZ
CSB-EP487389DZZ
CSB-BP487389DZZ
CSB-MP487389DZZ
CSB-EP487389DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH) CSB-YP487390DZZ
CSB-EP487390DZZ
CSB-BP487390DZZ
CSB-MP487390DZZ
CSB-EP487390DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Phosphopantetheine adenylyltransferase (coaD) CSB-YP487391DZZ
CSB-EP487391DZZ
CSB-BP487391DZZ
CSB-MP487391DZZ
CSB-EP487391DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. UPF0296 protein PCC7424_3427 (PCC7424_3427) CSB-YP487392DZZ
CSB-EP487392DZZ
CSB-BP487392DZZ
CSB-MP487392DZZ
CSB-EP487392DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Photosystem II reaction center protein T (psbT), partial CSB-YP487393DZZ
CSB-EP487393DZZ
CSB-BP487393DZZ
CSB-MP487393DZZ
CSB-EP487393DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Photosystem II reaction center protein I (psbI), partial CSB-YP487394DZZ
CSB-EP487394DZZ
CSB-BP487394DZZ
CSB-MP487394DZZ
CSB-EP487394DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. 30S ribosomal protein S20 (rpsT) CSB-YP487395DZZ
CSB-EP487395DZZ
CSB-BP487395DZZ
CSB-MP487395DZZ
CSB-EP487395DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (gpmI), partial CSB-YP487396DZZ
CSB-EP487396DZZ
CSB-BP487396DZZ
CSB-MP487396DZZ
CSB-EP487396DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. ATP synthase epsilon chain (atpC) CSB-YP487397DZZ
CSB-EP487397DZZ
CSB-BP487397DZZ
CSB-MP487397DZZ
CSB-EP487397DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. Cytochrome b559 subunit alpha (psbE), partial CSB-YP487398DZZ1
CSB-EP487398DZZ1
CSB-BP487398DZZ1
CSB-MP487398DZZ1
CSB-EP487398DZZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cyanothece sp. UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP487399DZZ
CSB-EP487399DZZ
CSB-BP487399DZZ
CSB-MP487399DZZ
CSB-EP487399DZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>